関連する実験動画
Updated: Jul 16, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
レプチンによる減量におけるステアロイル-CoAデサチュラゼ-1の役割
Paul Cohen1, Makoto Miyazaki, Nicholas D Socci
1Laboratory of Molecular Genetics, Center for Studies in Physics and Biology, Rogosin Institute, Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.
Science (New York, N.Y.)
|July 13, 2002
まとめ
レプチン レプチンは,レプチンの
科学分野:
- メタボリック研究.
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- レプチンの代謝効果は食欲抑制を超えて広がっています.
- レプチンの代謝作用の正確なメカニズムについては,さらなる解明が必要である.
研究 の 目的:
- 転写プロファイリングを使用して,肝臓内のレプチン調節遺伝子を特定する.
- レプチンの代謝効果を媒介する肝臓ステアロイル-CoAデサチュラゼ-1 (SCD-1) の役割を調査する.
主な方法:
- オブ/オブマウス肝臓での転写プロファイリングを使用して,レプチン調節遺伝子を特定しました.
- ネズミの代謝パラメータに対するステアロイル-CoAデサチュラゼ-1 (SCD-1) 遺伝子変異の影響を評価した.
主要な成果:
- レプチンは特に,肝臓のステアロイル-コア脱酸化酵素-1 (SCD-1) のRNAレベルと酵素活性を抑制しました.
- SCD-1が欠けていたマウスは痩せ,超代謝を示した.
- SCD-1変異を持つ肥満/肥満マウスは,肥満が減り,エネルギー消費が増加し,肝臓のトリグリセリドとVLDLの生成が低下した.
結論:
- 肝中のステアロイル-コア脱酸化酵素-1 (SCD-1) のダウン調節は,レプチンの代謝作用の重要なメカニズムである.
- SCD-1をターゲットにすることで,代謝障害に対する治療戦略を提供することができる.
関連する概念動画
01:06Lipid Digestion
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...